+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sandoz AG - logo

Sandoz is recognized as the global leader in biosimilars and generic antibiotics, dermatology and transplantation medicines. It also holds leading global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology, respiratory and hormonal therapeutics. Its products are sold in more than 160 countries, and reach more than 500 million patients. The company was founded in 1946 and is based in Princeton, New Jersey.

From
Infliximab - Biosimilars Insight, 2020 - Product Thumbnail Image

Infliximab - Biosimilars Insight, 2020

  • Report
  • August 2020
  • 90 pages
From
Adalimumab - Biosimilar Insight, 2021 - Product Thumbnail Image

Adalimumab - Biosimilar Insight, 2021

  • Drug Pipelines
  • May 2021
  • 120 Pages
From
Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • October 2016
  • 80 Pages
From
From
From
From
From
Loading Indicator
adroll